Proopiomelanocortin gene expression and obesity
阿黑皮质素原基因表达与肥胖
基本信息
- 批准号:7069676
- 负责人:
- 金额:$ 27.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Obesity and associated metabolic disorders including diabetes have become epidemic worldwide and threaten the health of millions. A recent confluence of data from human population genetics studies, mouse transgenic experiments, and neuropeptide pharmacology has implicated the proopiomelanocortin (POMC) gene, its encoded peptides, and their cognate G-protein coupled receptors as essential components of the neural circuits that regulate food intake and energy expenditure. Evolution has resulted in functionally and topographically distinct DNA regulatory elements that control POMC transcription in either neurons or pituitary endocrine cells, and which are highly conserved across mammalian species. These distinctions in cell-type specific POMC promoter and enhancer elements are mirrored by unique complements of transcription factors that differentially regulate POMC gene expression in the brain versus pituitary gland. POMC expression in hypothalamic neurons is quantitatively associated with adipose mass over the lifetime of a mouse and we hypothesize that in humans the analogous control of neuronal POMC gene expression is a key regulatory switch determining the ultimate balance of fat storage or utilization. The first aim of this project is to further characterize the neuronal-specific enhancer elements of the POMC gene using a combination of in vivo transgenic and in vitro primary neuronal culture expression systems, guided by additional cross-species comparative sequencing. A second aim will specifically determine the interaction of POMC gene regulatory elements with components of the leptin receptor-signaling pathway to result in activation of neuronal POMC gene transcription by the adipocyte-derived hormone. Third, the quantitative and qualitative effects of selective neural enhancer mutations in the context of the endogenous mouse POMC gene will be rigorously tested by genetic knock-in strategies. Fourth, the mRNA "transcriptome" of POMC neurons isolated by lasercapture microscopy will be defined, and the cognate DNA-binding transcription factors responsible for neuron-specific POMC gene expression will be identified and cloned using both computational genomics and screening of yeast one-hybrid cDNA libraries constructed from amplified POMC neuron-specific RNA. Throughout these studies we will collaborate with our clinical colleagues, who are involved in human genome-wide screens and index case-based gene sequencing projects, in a translational effort to identify and functionally characterize additional polymorphic alleles of either the POMC gene itself or candidate neuronal POMC gene transcription factors underlying altered weight regulation.
描述(由申请人提供):包括糖尿病在内的肥胖和相关代谢疾病已在全球流行,并威胁着数百万的健康。人群遗传学研究,小鼠转基因实验和神经肽药理学的数据最近汇合的融合暗示了proopiomelananocortin(POMC)基因,其编码的肽以及其同源G蛋白偶联受体是调节食物摄入量的神经环形的必不可少的成分。进化导致功能和地形上不同的DNA调节元件控制神经元或垂体内分泌细胞中的POMC转录,并且在哺乳动物物种中高度保守。细胞类型的特异性POMC启动子和增强子元件中的这些区别反映了转录因子的独特补充,这些互补因素差异地调节了大脑与垂体中的POMC基因表达。下丘脑神经元中的POMC表达与小鼠一生中的脂肪质量相关,我们假设在人类中,神经元POMC基因表达的类似控制是确定脂肪储存或利用的最终平衡的关键调节开关。该项目的第一个目的是进一步表征POMC基因的神经元特异性增强子元素,使用体内转基因和体外原发性神经元培养表达系统的组合,并以其他跨体性比较测序为指导。第二个目标将特异性确定POMC基因调节元件与瘦素受体信号途径的成分的相互作用,从而导致通过脂肪细胞衍生的激素激活神经元POMC基因转录。第三,在内源性小鼠POMC基因的背景下,选择性神经增强子突变的定量和定性作用将通过遗传敲击策略进行严格测试。 Fourth, the mRNA "transcriptome" of POMC neurons isolated by lasercapture microscopy will be defined, and the cognate DNA-binding transcription factors responsible for neuron-specific POMC gene expression will be identified and cloned using both computational genomics and screening of yeast one-hybrid cDNA libraries constructed from amplified POMC neuron-specific RNA.在这些研究中,我们将与我们的临床同事合作,他们参与人类全基因组筛查和基于索引的基因测序项目,以转化努力,以识别并在功能上表征POMC基因本身或候选神经元POMC基因转录因子的其他多态性等位基因的其他多态性等位基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MALCOLM James LOW其他文献
MALCOLM James LOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MALCOLM James LOW', 18)}}的其他基金
Neurochemistry/Physiology of Proopiomelanocortin Neurons
阿黑皮素原神经元的神经化学/生理学
- 批准号:
7998421 - 财政年份:2010
- 资助金额:
$ 27.62万 - 项目类别:
Proopiomelanocortin gene expression and obesity
阿黑皮质素原基因表达与肥胖
- 批准号:
7247207 - 财政年份:2004
- 资助金额:
$ 27.62万 - 项目类别:
Proopiomelanocortin Gene Expression and Obesity
阿黑皮质素原基因表达与肥胖
- 批准号:
8076727 - 财政年份:2004
- 资助金额:
$ 27.62万 - 项目类别:
Proopiomelanocortin Gene Expression and Obesity
阿黑皮质素原基因表达与肥胖
- 批准号:
8254435 - 财政年份:2004
- 资助金额:
$ 27.62万 - 项目类别:
Proopiomelanocortin gene expression and obesity
阿黑皮质素原基因表达与肥胖
- 批准号:
9904617 - 财政年份:2004
- 资助金额:
$ 27.62万 - 项目类别:
Proopiomelanocortin Gene Expression and Obesity
阿黑皮质素原基因表达与肥胖
- 批准号:
8639543 - 财政年份:2004
- 资助金额:
$ 27.62万 - 项目类别:
Proopiomelanocortin gene expression and obesity
阿黑皮质素原基因表达与肥胖
- 批准号:
7455205 - 财政年份:2004
- 资助金额:
$ 27.62万 - 项目类别:
Proopiomelanocortin gene expression and obesity
阿黑皮质素原基因表达与肥胖
- 批准号:
10380168 - 财政年份:2004
- 资助金额:
$ 27.62万 - 项目类别:
Proopiomelanocortin gene expression and obesity
阿黑皮质素原基因表达与肥胖
- 批准号:
6923694 - 财政年份:2004
- 资助金额:
$ 27.62万 - 项目类别:
相似国自然基金
胃肠道Goblet细胞来源的TFF3通过与肝细胞表面TLR4受体结合保护酒精性肝损伤的机制探究
- 批准号:82370601
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ACP5上调调节性T细胞表面受体Layilin在诱导肝细胞癌免疫耐受中的作用与机制研究
- 批准号:82303149
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向c-MET以及CD133的串联双靶点嵌合抗原受体—巨噬细胞(CAR-M)对胰腺癌的杀伤及化疗协同增效作用及机制研究
- 批准号:82373230
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
炎症激活成纤维细胞表面受体TREM-1进而诱导异常成骨分化及后纵韧带骨化的机制研究
- 批准号:82372452
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
多价核酸调控细胞表面受体改变细胞表型转化
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 27.62万 - 项目类别:
Deciphering the lipid composition of primary cilia in human metabolic disease
破译人类代谢疾病中初级纤毛的脂质成分
- 批准号:
10696465 - 财政年份:2023
- 资助金额:
$ 27.62万 - 项目类别:
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion. Project 2
红细胞输注同种免疫的基本和转化机制。
- 批准号:
10711669 - 财政年份:2023
- 资助金额:
$ 27.62万 - 项目类别:
Cell-Meditated Inflammatory Pathway and Diabetic Retinopathy
细胞介导的炎症途径和糖尿病视网膜病变
- 批准号:
10368669 - 财政年份:2022
- 资助金额:
$ 27.62万 - 项目类别:
Deciphering the specificity and molecular mechanisms of regulatory T cells using novel approaches
使用新方法破译调节性 T 细胞的特异性和分子机制
- 批准号:
10576791 - 财政年份:2022
- 资助金额:
$ 27.62万 - 项目类别: